Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

CenExel Announces Formation of Task Forces to Advance Patient-Focused Clinical Research

DRAPER, UTAH / ACCESS Newswire / October 16, 2025 / CenExel, a leading, wholly owned clinical research site network, announces the formation of the CenExel Task Forces, designed to strengthen collaboration, enhance scientific innovation, and further elevate patient care across its nationwide network.

The new CenExel Task Forces, which are focused on Psychiatry, Pain, and Metabolic research, unite key opinion leaders and operational experts from across CenExel's nineteen Centers of Excellence to advance clinical research through shared expertise, strategic alignment, and collaboration.

Task Force Leadership

  • Psychiatry Task Force: David Walling, PhD, Chief Scientific Director, CenExel Psychiatry

  • Pain Task Force: Todd Bertoch, MD, Chief Medical Director, CenExel Pain

  • Metabolic Task Force: Kimball Johnson, MD, Chief Medical Director, CenExel Metabolic

These therapeutic task forces will drive CenExel's mission to put patients first by optimizing trial design and delivery, ensuring access to innovative therapies, and reinforcing consistency and quality across the network. The initiative also strengthens the partnership between scientific and operational leaders, enabling CenExel to provide sponsors and CROs with even greater data quality and reliability.

"Our leadership team is the backbone of CenExel," said Ryan Brooks, CenExel's Chief Executive Officer. "These new Task Forces harness the collective expertise and compassion of our most experienced clinicians and researchers. By bringing them together to share insights and align strategy, we're ensuring that every decision - scientific, operational, and commercial - ultimately support the patients in our communities who trust us with their care."

In conjunction with the Task Force initiative, CenExel also announced several leadership appointments that reflect the company's continued investment in operational excellence and scientific depth:

  • Jennifer Clifton - Executive Site Director, CenExel Savannah

  • Karen Ortiz - Executive Site Director, CenExel Denver

  • Jane Joaquine - Executive Site Director, CenExel Riverside

  • Vera Grindell - Regional Rater Trainer, CenExel West

The Task Forces will convene regularly to align scientific and operational priorities: monthly full-team meetings to share strategy and insights, biweekly subgroup sessions to focus on therapeutic or functional areas, and quarterly reviews with executive leadership to guide network-wide growth and innovation.

CenExel's establishment of these Task Forces reflects its ongoing commitment to advancing clinical research with a patient-first mindset by combining scientific rigor, compassionate care, and deep community engagement to deliver meaningful breakthroughs for patients and their families.

Contact Information
Sara Koeblin
Director of Corporate Communications
s.koeblin@cenexel.com
(617) 639-6075

.

SOURCE: CenExel Research



View the original press release on ACCESS Newswire

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.